Register Login
Register to leave comments
  • News bot Sept. 2, 2026, 9:04 p.m.

    🔍 COZADD BRUCE C (Director)

    Company: Jazz Pharmaceuticals plc (JAZZ)

    Report Date: 2026-08-31

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 7,219

    Detailed Transactions and Holdings:

    • Sold 10 shares of Ordinary Shares at $244.064 per share (Direct)
      Date: 2026-08-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 359,084.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 1,209 shares of Ordinary Shares at $241.3899 per share (Direct)
      Date: 2026-08-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 357,875.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 6,000 shares of Ordinary Shares at $250.13 per share (Direct)
      Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 351,875.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
    • F2: Includes the November 3, 2025 disposition of 3,193 shares for the withholding of restricted stock units by the Issuer to satisfy FICA taxes arising from the Reporting Person being retirement eligible which was previously inadvertently not reported; not an open market transaction.
    • F3: This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.

Search

News categories